Richa Saxena

Has grant

Professor of Anaesthesia

Harvard Medical School
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Ethical, multimodal AI tool for prediction of preeclampsia risk in early pregnancy

Open Date: 2025-09-01

Close Date: 2026-08-31

Grant: Open

Genomics-guided sleep biomarker discovery for early Alzheimer's disease: A wearables study

Open Date: 2024-07-01

Close Date: 2029-04-30

Grant: Open

Modulation of sensitivity to light as a mechanism for antidepressant treatment efficacy

Open Date: 2023-11-01

Close Date: 2029-09-30

Grant: Close

Circadian photoreceptor sensitivity and impacts of modern lighting on sleep

Open Date: 2023-04-24

Close Date: 2026-04-23

Grant: Open

Long COVID as a putative subtype of chronic fatigue syndrome

Open Date: 2022-08-18

Close Date: 2027-07-31

Articles (20)

Objective We examined whether meal timing is associated with long‐term weight‐loss maintenance and whether meal timing interacts with a genome‐wide polygenic score (PRS‐BMI) on body weight‐related outcomes. We then examined the interaction of meal timing with 97 BMI‐related single‐nucleotide polymorphisms on obesity outcome. Methods Participants ( N = 1195, mean age 41.07 [SD 12.68] years, female 80.8%, baseline mean BMI 31.32 [SD 5.53] kg/m 2 ) were adults with overweight or obesity from the Obesity, Nutrigenetics, Timing, and Mediterranean (ONTIME) study. We developed a PRS‐BMI to assess the genetic risk for obesity and estimated the timing of the midpoint of meal intake. We also calculated the success in long‐term weight‐loss maintenance after a dietary obesity treatment (at least 3 years). Linear regression analyses were performed for association and interaction assessments. Results Each hour of delay in meal timing was associated with 2.2% higher long‐term body weight (β [SE] = 2.177% [1.067%]; p = 0.042) (i.e., with lower weight‐loss maintenance following dietary obesity treatment). There was a significant interaction between meal timing and PRS‐BMI ( p = 0.008); BMI increased by more than 2 kg/m 2 for every hour of delay in meal timing in individuals with high PRS‐BMI (β [SE] = 2.208 [0.502] kg/m 2 ; p = 1.0E‐5), whereas no associations were evident for those with lower genetic risk. Conclusions Meal timing is associated with weight‐loss maintenance and may influence the association between obesity genetics and BMI. Findings underscore the importance of personalized obesity management. image

Year:

2025

Objective In this cross‐sectional study, we aim to investigate the interactions between obesity, siesta behavior, and the genetic propensity for siesta in a Mediterranean population, in whom siesta is deeply rooted. Methods We applied a previously generated Siesta‐Polygenic Score (PGS) in the ONTIME study ( n = 1278). Siesta and other Mediterranean lifestyle behaviors were characterized using questionnaires. We further determined obesity grade. Secondarily, we measured weight loss during treatment as well as long‐term weight‐loss maintenance. Logistic regression analyses were performed to address our aim. Results A total of 42.4% of the population usually took siesta. A significant genetic influence on siesta propensity was found, with a higher genetic predisposition linked to taking siesta more frequently (odds ratio [OR] = 1.17, 95% CI: 1.03–1.32; p = 0.015). Participants with a higher genetic propensity for siesta showed poorer dietary habits ( p < 0.05). Among individuals with a high genetic propensity for siesta, we found that those who usually take siesta have lower odds of having obesity ( p = 0.038) compared with those who do not. Similarly, in exploratory analysis, among individuals with a high genetic propensity for siesta, we found that those who usually take siesta have higher odds of weight‐loss success ( p = 0.007) compared with those who do not. Conclusions Considering the ongoing debate regarding whether siesta is beneficial or detrimental, our findings suggest that individual genetic predisposition to siesta might influence the association between siesta and health. image

Year:

2025

Insomnia symptoms double the risk of cardiovascular disease (CVD), yet shared genetic pathways remain unclear. Genome-wide association studies identified a genetic locus (near ATP5G1, UBE2Z, SNF8, IGF2BP1 and GIP) linked to insomnia and CVD. We used Drosophila models to perform tissue-specific RNA interference knockdowns of four conserved orthologs (ATPsynC, lsn, Bruce and Imp) in neurons and the heart. Neuronal-specific knockdown of ATPsynC, Imp and lsn impaired sleep quantity and quality. In contrast, cardiac knockdown of ATPsynC and lsn reduced cardiac function and lifespan, with lsn knockdown also causing cardiac dilation and myofibrillar disorganization. Cross-tissue effects were evident: neuronal Imp knockdown compromised cardiac function, whereas cardiac ATPsynC and lsn knockdown increased sleep fragmentation and inflammation (marked by Upd3 elevation in the heart or head). Overexpression of Upd3 in neurons impaired cardiac function, and its overexpression in the heart disrupted sleep. Our findings reveal conserved genes mediating tissue-specific and cross-tissue interactions between sleep and cardiac function, providing novel insights into the genetic mechanisms linking insomnia and CVD through inflammation.

Year:

2025

Study Objectives Excessive daytime sleepiness (EDS), influenced by environmental and social-behavioral factors, is reported by a subset of patients with sleep apnea—a group that may be at elevated cardiovascular risk. However, it is unclear whether sleep apnea with and without EDS have distinct genetic underpinnings. In this study, we perform gene-by-EDS interaction analyses for apnea hypopnea index, a diagnostic marker of sleep apnea severity, to understand EDS’s influence on its underlying genetic risk. Methods Discovery interaction analyses for common variants and gene-based rare variants were conducted respectively using multi-ethnic Trans-Omics for Precision Medicine (N = 11 619) data, followed by replication and subsequent meta-analysis in additional Trans-Omics for Precision Medicine-imputed data (N = 8904). The 1 degree-of-freedom (1df) G × E test and the 2df joint G,G × E tests were utilized. Sex-stratified analyses were additionally performed. Results Discovery analysis revealed two common intronic variants—rs13118183 (CCDC3) and rs281851 (MARCHF1)—and three rare variant gene sets mapped to SCUBE2, TMEM26, and CPS4FL—to exhibit interaction with EDS. Meta-analysis revealed EDS interaction with 11 rare variant gene sets mapped to UBLCP1, MED31, RAP1GAP, CPNE5, MYMX, YY1, ZNF773, YBEY, IQCB1, PI4K2B, and CORO1A. Conclusion Genetic loci reveal connections to cardiovascular risk, insulin resistance, thiamine deficiency, and resveratrol mechanism. Discovered genetic signals may offer insight into pertinent biological pathways for sleep apnea patients with an excessively sleepy subtype. Statement of Significance Sleep apnea is a complex sleep disorder. Exemplifying this is the disparately varying estimates of presence of excessive daytime sleepiness (EDS) in patients, and persistent EDS that lingers despite treatment. Some data indicate that the excessively sleepy subtype of sleep apnea carries heightened cardiovascular risk. Whether EDS influences genetic risk factors underlying sleep apnea has not yet been investigated. This study addresses this gap, as the first genome-wide gene × EDS interaction study for apnea hypopnea index, the standard sleep apnea severity metric. Genetic loci that have been previously unconsidered for sleep apnea are revealed. Discovered interaction signals highlight pathways in metabolism, genes associated with cardiometabolic traits, and therapeutic agents influencing obesity, blood pressure, oxidative stress, and apnea hypopnea index.

Year:

2025

Aims/hypothesis Suboptimal sleep health is linked to higher risks for incident type 2 diabetes. We aimed to assess the clinical utility of adding self-reported sleep traits to a type 2 diabetes prediction model. Methods In this cohort study, we used UK Biobank data and Cox proportional hazards models to examine how self-reported sleep duration and insomnia symptoms were associated with incident type 2 diabetes risk. Harrell’s C statistic and net reclassification improvement (NRI) were used to assess whether sleep traits improved the incident type 2 diabetes discrimination and predictive utility achieved using QDiabetes variables, with and without including a type 2 diabetes polygenic risk score (PGS). Independent replication was explored in the Nurses’ Health Study, the Nurses’ Health Study II and the Health Professionals Follow-up Study. Results Extremes of sleep duration and occasional or frequent insomnia symptoms were associated with higher risks for incident type 2 diabetes. In the UK Biobank and replication cohorts, adding sleep traits to the QDiabetes risk score did not improve type 2 diabetes prediction (C statistic: QDiabetes alone 0.8933; QDiabetes + sleep duration 0.8939; QDiabetes + insomnia 0.8931; QDiabetes + sleep traits 0.8935). The corresponding total NRI values were: 0.08 (95% CI −0.18, 0.33), 0.04 (95% CI −0.08, 0.16) and 0.04 (95% CI −0.10, 0.18). Inclusion of PGS data marginally improved the type 2 diabetes risk prediction achieved using The QDiabetes calculator, with or without the inclusion of sleep traits in the model (QDiabetes + PGS: C statistic 0.8945; total NRI 0.20 [95% CI 0.12, 0.28]; QDiabetes + PGS + sleep traits: C statistic 0.8946; total NRI 0.18 [95% CI 0.09, 0.27]). Conclusions/interpretation While sleep duration and insomnia symptoms were associated with type 2 diabetes risk, they are not useful for improving type 2 diabetes prediction beyond QDiabetes model performance. Inclusion of a type 2 diabetes PGS marginally improved prediction but lacked clear clinical utility. Graphical Abstract

Year:

2025

Year:

2025

Year:

2025

Background Sleep apnoea is a common sleep disorder affecting at least 10% of the population. It is caused by lack of breathing during sleep, typically mediated by obstruction of airways or less frequently by misdirected central signals for breathing. The primary risk factor is a high body mass index, causing airway obstruction. However, understanding risk factors for sleep apnoea in non-obese (body mass index 0.8), and single-cell sequencing implicated HTR1F expression, particularly in neurons. Analysis of expression quantitative trait locus data further supported a possible regulatory role in neurons (β= −0.03, p=1.2×10 −4 ). Finally, phenome-wide association study analysis of rs1818163 showed an association with objectively measured sleep-activity data, specifically with the number of awakenings during the night (p=5.6×10 −8 ). Conclusions The findings indicate that HTR1F is associated with sleep apnoea, particularly in the non-obese patient population, and provide insight into the growing evidence of serotonin signalling as a factor modulating liability to sleep apnoea.

Year:

2025

Modern lifestyles often disturb circadian rhythms, yet the genetic circuits that convert this stress into metabolic dysfunction remain poorly defined. Here, we identify a missense variant in ADCY3 (rs11676272; Ser107Pro) as a pleiotropic regulator of circadian preference and adiposity. Using genome-wide pleiotropy analysis in ∼480,000 UK Biobank participants, we show that the G risk allele (Pro107) increases morningness, BMI, and fat mass in European (N=451,324) and African (N=8,738) ancestry groups, with behavioral amplification by morning difficulty awakening observed in Europeans, power limited interaction modeling in other populations. Structural modeling and transcriptomic analysis suggest this allele destabilizes ADCY3 and alters adipose-specific splicing and expression. In mice, Adcy3 is rhythmically expressed in adipose tissue, with the conserved Pro107 site showing BMAL1 binding and cold-inducible activation. Human adipose ADCY3 expression also increases after weight loss. Together, these findings reveal a genotype-dependent, behaviorally modifiable axis linking difficulty awakening to adipose thermogenesis and obesity risk.

Year:

2025

Study Objectives Chronotype, a manifestation of circadian rhythms, affects morning or evening preferences and ease of getting up. This study explores the genetic basis of morning chronotype and ease of getting up, focusing on the G-protein-coupled receptor locus, GPR61. Methods We analyzed the genetic correlation between chronotype and ease of getting up using linkage disequilibrium score regression with summary statistics from the UK Biobank (n = 453,379). We prioritized shared signals between chronotype and ease of getting up using the Human Genetic Evidence (HuGE) score. We assessed the significance of GPR61 and the lead variant rs12044778 through co-localization and in silico analyses from ENCODE, Genotype-Tissue Expression, Hi-C, and Knockout Mouse Project databases to explore potential regulatory roles of causal genes. Results We identified a strong genetic correlation (Rg = 0.80, p = 4.9 × 10324) between chronotype and ease of getting up. Twenty-three genes, including three circadian core clock components, had high HuGE scores for both traits. Lead variant rs12044778 in GPR61 was prioritized for its high HuGE score (45) and causal pleiotropy (posterior probability = 0.98). This morningness variant influenced gene expression in key tissues: decreasing GPR61 in tibial nerve, increasing AMIGO1 in subcutaneous adipose, and increasing ATXN7L2 in the cerebellum. Functional knockout models showed GPR61 knockout increased fat mass and activity, AMIGO1 knockout increased activity, and ATXN7L2 knockout reduced body weight without affecting activity. Conclusions Our findings reveal pleiotropic genetic factors influencing chronotype and ease of getting up, emphasizing GPR61’s rs12044778 and nearby genes like AMIGO1 and ATXN7L2. These insights advance our understanding of circadian preferences and suggest potential therapeutic interventions.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (42)

Hanna Ollila

University of Helsinki

FINLAND
View details

Renato Polimanti

Yale University School of Medicine

UNITED STATES
View details

Jonathan K Pritchard

Stanford University

UNITED STATES
View details

Marta Garaulet

Professor of Physiology and Nutrition

Universidad de Murcia

SPAIN
View details

Tuula Palotie

University of Helsinki

FINLAND
View details

Laura Raffield

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

David Ray

Professor of Endocrinology

University of Oxford

UNITED KINGDOM
View details

Priit Palta

Professor of Translational Genomics

University of Tartu

ESTONIA
View details

Simon Kyle

Professor

University of Oxford

UNITED KINGDOM
View details

Girish Melkani

The University of Alabama

UNITED STATES
View details

Han Chen

Professor

NYU School of Medicine

UNITED STATES
View details

Tian Ge

Broad Institute

UNITED STATES
View details

Lyle John Palmer

Professor

University of Adelaide

AUSTRALIA
View details

Timothy Frayling

NHS research training fellow, Lecturer, Senior Lecturer, Professor

University of Exeter

UNITED KINGDOM
View details

Stephanie Zellers

University of Helsinki

FINLAND
View details

Aarno Palotie

University of Helsinki

FINLAND
View details

Michael N Weedon

Associate Professor

University of Exeter Medical School

UNITED KINGDOM
View details

Nasa Sinnott-Armstrong

Assistant Professor

Fred Hutch Cancer Center

UNITED STATES
View details

Lea Urpa

University of Helsinki

FINLAND
View details

Aurora Aragón-Alonso

Associate Professor

Universidad de Murcia

SPAIN
View details

Frank Scheer

Associate Member

Broad Institute

UNITED STATES
View details

Martin Rutter

Professor of Cardiometabolic Medicine

The University of Manchester

UNITED KINGDOM
View details

Rocío Jiménez de la Peña Armada

Assistant Professor

Universidad Complutense de Madrid

SPAIN
View details

Andrew Wood

Lecturer in Statistical Genetics and Health Data Science

University of Exeter

UNITED KINGDOM
View details

Jacqueline Lane

Assistant Professor

Brigham and Women's Hospital

UNITED STATES
View details

Victoria Garfield

Senior Lecturer

University of Liverpool

UNITED KINGDOM
View details

James Walker

Assistant Professor

Massachusetts General Hospital

UNITED STATES
View details

Hassan Dashti

Assistant Professor

Broad Institute

UNITED STATES
View details

Adel Bachour

University of Helsinki

FINLAND
View details

Martin Broberg

University of Helsinki

FINLAND
View details

Samuli Ripatti

University of Helsinki

FINLAND
View details

Andrew Phillips

MONASH UNIVERSITY

AUSTRALIA
View details

Brian Cade

Investigator

Brigham and Women's Hospital

UNITED STATES
View details

SINA A. GHARIB

University of Washington

UNITED STATES
View details

Diego Salmerón Martínez

Universidad de Murcia

SPAIN
View details

Tianyi Huang

Tenure-Track Investigator

National Institute on Aging

UNITED STATES
View details

Jaakko Kaprio

Research Director

University of Helsinki

FINLAND
View details

Alison Wright

The University of Manchester

UNITED KINGDOM
View details

Sean Cain

Professor

Flinders University

AUSTRALIA
View details

Jukka Koskela

University of Helsinki

FINLAND
View details

Sutapa Mukherjee

Flinders University

AUSTRALIA
View details

ANA ISABEL CASCALES SÁNCHEZ

Profesora en el Grado de Nutrición Humana y Dietética

Universidad de Murcia

SPAIN
View details